EDUKASI TENTANG PENTINGNYA MENGENAL DAMPAK DAN EFEK SAMPING METFORMIN HCL PADA MAHASISWA
DOI:
https://doi.org/10.29303/abdiinsani.v12i7.2680Keywords:
Socialization, Students, Metformin HCl, Diabetes, Education, HealthAbstract
Metformin HCl is an antidiabetic drug widely used in the management of type 2 diabetes mellitus. Although its effectiveness has been proven, understanding of the impacts and side effects of Metformin HCl remains limited among students, especially those from non-health-related backgrounds. This lack of knowledge can potentially lead to misuse or careless use of the medication. Therefore, this community service activity was carried out with the aim of increasing students' understanding of the risks, side effects, and proper use of Metformin HCl as part of preventive health education. The method used involved educational outreach through simple and engaging posters, along with evaluations conducted via pre-tests and post-tests. The activity involved 20 students from various study programs at Universitas Global Jakarta. The pre-test results showed that 80% of students lacked sufficient understanding of Metformin HCl, including its function, side effects, and usage. This indicates a low level of health literacy among students, particularly those from non-health disciplines, regarding this commonly used antidiabetic medication. Following the educational session, there was a significant increase in participants’ level of understanding. The post-test results showed that 100% of students reported understanding the material presented. This improvement indicates the effectiveness of the educational method used in this community service activity. Thus, education has proven to be a strategic step in raising awareness and understanding of rational drug use among students. In conclusion, an interactive educational approach using simple visual media has been proven effective in improving student literacy regarding drug use—specifically Metformin HCl—and in fostering awareness of the importance of managing sugar intake and understanding drug side effects wisely.
Downloads
References
ADA (American Diabetes Association), & EASD (European Association for the Study of Diabetes). (2023). EASD clinical practice guidelines: Metformin use in type 2 diabetes. Diabetologia, 66, 1–10. [https://doi.org/10.1007/s00125-023-05971-3](https://doi.org/10.1007/s00125-023-05971-3).
American Diabetes Association. (2023). Standards of medical care in diabetes 2023. Diabetes Care, 46(Suppl 1), S1–S264. [https://doi.org/10.2337/dc23-S001](https://doi.org/10.2337/dc23-S001).
Anwar, Y., An‑Naf, M. D., Lathiifah, M. P., Tiana, L., Hardianti, R., Puspitasari, D., Maharani, E. D., Fadillah, N. K., Tibbiya, F., Najmah, L., Kartika, Apriadi, J., Astuti, S., Alicia, Mahmudah, N., & Editia, I. M. D. (2022). Penyuluhan penyakit diabetes mellitus kepada remaja sekolah menengah atas di Jakarta Utara. Jurnal Pengabdian Masyarakat Farmasi: Pharmacare Society, 1(2), 43–53.
Fadilah, R., & Zainuddin, Z. (2020). Efek samping penggunaan metformin pada pasien diabetes mellitus tipe 2 di Puskesmas Makassar. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy), 6(2), 155–162.
Feronica, Y. (2021). Perbedaan asupan gula harian dan lingkar pinggang pada penyandang diabetes mellitus tipe 2 dan orang sehat. [Manuskrip tidak dipublikasikan].
Gupta, P., Sharma, A., & Verma, S. (2023). Metformin-associated lactic acidosis: Incidence and risk factors. Herald Open Access, 10(3), 45–52.
Johnson, M. E., & Patel, S. (2022). Drug interactions with metformin: Cimetidine, contrast agents, and more. Stat Pearls. [Internet]. [https://www.ncbi.nlm.nih.gov/books/NBK537175/](https://www.ncbi.nlm.nih.gov/books/NBK537175/)
Kementerian Kesehatan Republik Indonesia. (2018). Laporan nasional Riskesdas 2018. Badan Penelitian dan Pengembangan Kesehatan.
Kuna, M. R., Ananda, M., Manika, O., & Pobela, T. (2022). Analisis penggunaan obat pada pasien diabetes mellitus di Puskesmas Gogagoman tahun 2022. Jurnal Cakrawala Ilmiah, 2(4), 1631–1638.
Li, X., & Chen, Y. (2024). Interactive health education methods: Enhancing student engagement in chronic disease management. International Journal of Educational Research, 114, 101–130.
Miller, J. P., & Davis, S. R. (2024). Minimizing gastrointestinal effects of metformin: Probiotics and novel formulations. MDPI Pharmaceuticals, 17, 512–523.
Murti, N. W. H. M. H., Dewi, B. K., & Nurjanah, S. (2023). Penjangkauan dan pengendalian penyakit tidak menular diabetes melitus di Desa Tenajar Kecamatan Kertasamaya Kabupaten Indramayu. BEGAWE: Jurnal Pengabdian Masyarakat, 1(2), 58–65.
Rahayu, S., & Putri, E. K. (2019). Pemanfaatan metformin sebagai obat antiaging dan antiobesitas: Tinjauan literatur. Jurnal Ilmu Kefarmasian Indonesia, 17(1), 1–9.
Rangkuti, I. (2022). Edukasi dampak metformin sebagai tambahan obat pada penderita kanker payudara di Rumah Sakit Grand Medistra Deli Serdang. Pengabdian Deli Sumatera, 1(2).
Retno Nugraheni, S., & Isfandiari, W. (2022). Hubungan pengetahuan dan sikap mahasiswa kesehatan terhadap pencegahan diabetes mellitus tipe 2. Jurnal Kesehatan Mahasiswa.
Sari, D., & Wijaya, A. (2022). Faktor risiko diabetes mellitus pada dewasa di Indonesia: Studi cross-sectional. Jurnal Epidemiologi Nasional, 3(1), 12–23.
Smith, J. A., & Lee, K. T. (2021). Gastrointestinal side effects of metformin: A meta-analysis. BMC Endocrine Disorders, 21, 105–114.
Tan, C. H., & Wong, M. (2023). Educational interventions for diabetes prevention in adolescents: A systematic review. Health Promotion International, 38(2), 223–234.
Zhang, L., & Thompson, R. (2022). Long-term metformin therapy and vitamin B₁₂ deficiency: A systematic review. *Frontiers in Endocrinology, 13, 828–834.
